A WORD FROM THE CHAIR
The Department of Pediatrics and Human Development is comprised of a diverse faculty who share a common concern for all aspects of human growth and development, both normal and abnormal. The Department has a statewide footprint with faculty in Lansing, Grand Rapids, Flint, Southfield, Midland, Traverse City, and Marquette/Escanaba. The Department has educational responsibilities at all levels in the curriculum of the College of Human Medicine. Its faculty participate in courses which relate biological, behavioral, and clinical sciences to child health. Departmental faculty play major roles in the new College of Human Medicine Shared Discovery Curriculum and its Learning Societies. The Department also has responsibility for general pediatric clerkships and pediatric subspecialty electives in the clinical medical curriculum. The Department participates actively in graduate medical education with three affiliated pediatric residency programs (with Sparrow Hospital in Lansing, Helen DeVos Children’s Hospital in Grand Rapids, and Hurley Children’s Hospital in Flint), three affiliated pediatric subspecialty fellowship programs (Perinatal-Neonatal Medicine in Lansing; Pediatric Hematology-Oncology and Pediatric Critical Care Medicine in Grand Rapids), and in CME. In addition, faculty members work with students in other graduate programs in the University. Individual faculty members of the Department participate in patient care and render medical consultation services in their respective subspecialty areas. The research endeavors of the departmental faculty are expanding and aim to help create a healthier, better functioning society by improving the health and wellbeing of the child and family.
B. Keith English, MD
Professor and Chair
DEPARTMENT OF PEDIATRICS AND HUMAN DEVELOPMENT
Pediatrics and Human Development Professor and Associate Chair for Research André S. Bachmann, PhD has been awarded $461,318.00 by the National Cancer Institute in an R21 to design and characterize novel, natural products-inspired ODC inhibitors with activity in pediatric neuroblastoma. Please join us in congratulating Dr. Bachmann and wishing him and his lab the best in their studies to come.
We are pleased to announce Professor and Associate Chair for Research André S. Bachmann, PhD has been awarded a grant from St. Baldrick's Foundation to help fund his ongoing efforts to find novel treatments for neuroblastoma. This often-lethal pediatric cancer affects 1 in 7,000 children, accounting for 15% of cancer deaths in children.
St. Baldrick's is the largest private funder of childhood cancer research grants. Dr. Bachmann's is one of 76 grants awarded by St. Baldrick's this year alone, the combined funds of which total more than $19.1 million dollars.
Please join us in thanking St. Balderick's for this generous award, and in congratulating Dr. Bachmann on his continued success.
It's that time of the year again!
The annual Great Strides 5K walk will be held Saturday, June 9, 2018, at Hawk Island Park in Lansing. This family-friendly event will include a DJ, Zumba, pizza, cookies, cake, Big Lug, Sparty, and plenty of fun. Please join us at the finish line and support our friends with CF.
Registration begins at 10:00 AM. The walk begins at 11:00 AM. Registration is free, but walkers are encouraged to raise funds. Your support will help accelerate innovative research and drug development and support ongoing advanced care and advocacy programs.Read more ...
The MSU College of Human Medicine's new Grand Rapids Research Center is now open for business, and our very own Professor André S. Bachmann is the $88.1 million facility's first tenant. To document the event, the College had a film crew follow Dr. Bachmann and a team of very busy movers as they relocated the Bachmann Lab to its new home. Take a look:
Pediatrics and Human Development researcher André Bachmann has been awarded an ADVANCE Grant in the amount of $80,000 for his study of TIR-199 as a potential proteasome inhibitor. The ADVANCE Fund is administered by Michigan State University and the Michigan Strategic Fund through the Michigan Economic Development Corporation, and is intended to incentivize public faculty with early-stage technologies to advance their research. Please join us in congratulating Dr. Bachmann and wishing him great success in yet another fascinating endeavor.